Search Results - "Ramirez, Muriel Garcia"
-
1
A double-blind phase III trial of immunomodulating nutritional formula during adjuvant chemoradiotherapy in head and neck cancer patients: IMPATOX
Published in The American journal of clinical nutrition (01-12-2020)“…In a previous phase II study an immunonutrient supplement was found to reduce severe acute toxicities for head and neck squamous cell cancer (HNSCC) patients…”
Get full text
Journal Article -
2
Standard versus fractionated high-dose cisplatin plus radiation for locally advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized phase II trial
Published in Radiotherapy and oncology (01-08-2024)“…•The 4-day fractionated regimen allows significantly more patients to receive a third cycle of cisplatin, with fewer dose reductions than the standard regimen…”
Get full text
Journal Article -
3
Induction chemotherapy (IC) with EXTREME study regimen for locally advanced head and neck cancer (LAHNC) frail patients
Published in Journal of clinical oncology (20-05-2017)“…Abstract only e17564 Background: IC with TPF (docetaxel, cisplatin, 5FU) in LAHNC is limited to fit patients (pts). We conducted a retrospective cohort study…”
Get full text
Journal Article -
4
Hyperfractionated reirradiation with cetuximab for recurrent head and neck cancer: The GORTEC 2008-01 multicentric phase II study
Published in Journal of clinical oncology (20-05-2018)“…Abstract only…”
Get full text
Journal Article -
5
Induction chemotherapy with the EXTREME regimen in frail patients with locally advanced head and neck squamous cell carcinoma
Published in Targeted oncology (01-04-2018)“…Background Induction chemotherapy (IC) with TPF (docetaxel, cisplatin, 5FU) for locally advanced head and neck squamous cell carcinoma (LAHNSCC) is limited to…”
Get full text
Journal Article -
6
Abstract PD3-05: Early results of the French multicenter, randomized SHARE trial comparing whole breast irradiation versus accelerated partial breast irradiation in postmenopausal women with early-stage breast cancer
Published in Cancer research (Chicago, Ill.) (01-03-2023)“…Purpose: The aim of current analyses is to report toxicity and cosmetic outcomes at 3 and up to 9 years of follow-up of post-menopausal patients randomized to…”
Get full text
Journal Article -
7
Double blind multicenter phase III GORTEC trial evaluating the efficacy of oral immune modulating formulae therapy during adjuvant radiochemotherapy in head and neck squamous cell carcinoma (HNSCC)
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
8
The case for a national prospective study on radiation therapy-induced lung toxicity
Published in Cancer radiothérapie (01-03-2008)Get full text
Journal Article